FR2867973A1 - Capillary care composition, useful to e.g. treat alopecia, comprises Sabal, which is an extract of Serenoa serrulata in association with a vehicle - Google Patents
Capillary care composition, useful to e.g. treat alopecia, comprises Sabal, which is an extract of Serenoa serrulata in association with a vehicle Download PDFInfo
- Publication number
- FR2867973A1 FR2867973A1 FR0403167A FR0403167A FR2867973A1 FR 2867973 A1 FR2867973 A1 FR 2867973A1 FR 0403167 A FR0403167 A FR 0403167A FR 0403167 A FR0403167 A FR 0403167A FR 2867973 A1 FR2867973 A1 FR 2867973A1
- Authority
- FR
- France
- Prior art keywords
- extract
- composition
- epilobium
- sabal
- serenoa serrulata
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/04—Preparations for permanent waving or straightening the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/10—Preparations for permanently dyeing the hair
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
La présente invention a trait à une composition de soin capillaireThe present invention relates to a hair care composition
contenant du sabal, qui est un extrait de baies de Serenoa Serrulata. Cette composition est notamment utile pour améliorer les séborrhées et les alopécies, en particulier séborrhéiques. containing sabal, which is an extract of Serenoa Serrulata berries. This composition is especially useful for improving seborrhea and alopecia, in particular seborrhoeic.
Les facteurs hormonaux jouent un rôle prépondérant dans la production de sébum et la pousse du poil. Il a ainsi été montré qu'à l'âge adulte, la production de sébum est plus élevée chez l'homme que chez la femme. En effet, les androgènes stimulent la production de sébum alors que les oestrogènes la diminuent. Dès son lo entrée dans la cellule, la testostérone est transformée en dihydrotestostérone (DHT) par la 5 aréductase présente dans la glande sébacée. Hormonal factors play a major role in sebum production and hair growth. It has been shown that in adulthood, sebum production is higher in men than in women. Indeed, androgens stimulate the production of sebum while estrogen decreases it. Upon entry into the cell, testosterone is converted to dihydrotestosterone (DHT) by the areductase present in the sebaceous gland.
La croissance du poil fait, quant à elle, intervenir des phénomènes complexes dans lesquels l'influence hormonale est dominante. En effet, les poils sont stimulés par les androgènes. As for hair growth, it involves complex phenomena in which the hormonal influence is dominant. Indeed, the hairs are stimulated by androgens.
Un effet anti-repousse poils d'un extrait de sabal a été associé à son action inhibitrice sur la 5 a-réductase (Carilla et al. 1984, Pannunzio et al. 1987). An anti-hair regrowth effect of a sabal extract has been associated with its inhibitory action on 5α-reductase (Carilla et al., 1984, Pannunzio et al., 1987).
Il a été démontré que l'extrait lipido-stérolique de sabal agit sur la conversion intracellulaire de la testostérone par la 5 a-réductase et interagit avec les récepteurs androgènes intracellulaires (Sultan et al. 1984). The lipid-sterol extract of sabal has been shown to act on the intracellular conversion of testosterone by α-reductase and interacts with intracellular androgen receptors (Sultan et al., 1984).
L'extrait altère la formation de DHT et inhibe fortement la 3 a-réductase cétostéroïde qui permet la conversion de la DHT en 5 a-androstane-3a 17 ss diol. Par ailleurs, l'extrait se révèle être un inhibiteur compétitif de la fixation des hormones androgènes sur leurs récepteurs. The extract alters the formation of DHT and strongly inhibits the 3-a-reductase ketosteroid which enables the conversion of DHT to 5a-androstane-3a 17s-diol. Moreover, the extract proves to be a competitive inhibitor of the binding of androgenic hormones to their receptors.
Le cheveu comme le poil est sous commande hormonale. La chute ou la pousse sont liées de facto à ce facteur hormonal. Toutefois, il semble que le cheveu subit une influence inverse par rapport à l'influence hormonale sur le poil. Le taux d'androgène au niveau de la peau favorise la pousse du poil dit sexuel (barbe, etc...). Or, ce taux d'androgène agit à l'inverse au niveau du cheveu, favorisant la chute de cheveux et l'augmentation du potentiel de sécrétion de la glande sébacée. The hair as the hair is under hormonal control. The fall or shoot is de facto linked to this hormonal factor. However, it seems that the hair undergoes an opposite influence with respect to the hormonal influence on the hair. The level of androgen in the skin promotes the growth of the so-called sexual hair (beard, etc ...). However, this androgen content acts inversely in the hair, favoring hair loss and increasing the secretion potential of the sebaceous gland.
Les inventeurs ont ainsi mis en évidence que l'application d'une composition comprenant du sabal sur le cuir chevelu produit une diminution de la sécrétion sébacée ainsi qu'une diminution de la chute du cheveu qui se poursuit durant toute la période d'application de ladite composition. The inventors have thus demonstrated that the application of a composition comprising sabal on the scalp produces a decrease in sebaceous secretion as well as a decrease in hair loss that continues throughout the period of application of the scalp. said composition.
L'invention fournit donc une composition de soin capillaire comprenant du sabal, qui est un extrait de Serenoa serrulata en association avec un véhicule cosmétiquement acceptable. The invention thus provides a hair care composition comprising sabal, which is an extract of Serenoa serrulata in combination with a cosmetically acceptable carrier.
Cette composition est utile pour la préparation d'un médicament destiné à la prévention ou au traitement des séborrhées du cuir chevelu, ainsi qu'à la io prévention ou au traitement des alopécies, en particulier des alopécies séborrhéiques. This composition is useful for the preparation of a medicament for the prevention or treatment of seborrhea of the scalp, as well as the prevention or treatment of alopecia, particularly seborrheic alopecia.
L'invention fournit également un procédé de traitement cosmétique destiné à diminuer la sécrétion sébacée du cuir chevelu etlou à diminuer la chute des cheveux, comprenant l'application sur le cuir chevelu d'une composition à base de sabal, telle que définie ici. The invention also provides a cosmetic treatment method for decreasing sebaceous secretion of the scalp and / or decreasing hair loss, comprising applying to the scalp a sabal composition as defined herein.
En particulier, la composition de soin capillaire selon l'invention comprend un extrait de Serenoa serrulata et au moins un extrait d'un végétal sélectionné dans le groupe constitué de Epilobium, de préférence Epilobium roseum, Cucurbita, de préférence Cucurbita pepo, Tropaeolum, de préférence Tropaeolum majus, Terminalia, de préférence Terminalia chebula, et Porphyridium, de préférence Porphyridium cuentum. L'association particulière de ces extraits végétaux permet d'obtenir une synergie de leurs effets. In particular, the hair care composition according to the invention comprises an extract of Serenoa serrulata and at least one extract of a plant selected from the group consisting of Epilobium, preferably Epilobium roseum, Cucurbita, preferably Cucurbita pepo, Tropaeolum, preferably Tropaeolum majus, Terminalia, preferably Terminalia chebula, and Porphyridium, preferably Porphyridium cuentum. The particular combination of these plant extracts makes it possible to obtain a synergy of their effects.
De manière préférentielle encore, ladite composition comprend la combinaison des extraits végétaux suivants: Serenoa serrulata, Epilobium 25 roseum, Curcubita pepo, Epilobium angustifolium, Tropaeolum majus, Terminalia chebula, Porphyridium cruentum. More preferably, said composition comprises the combination of the following plant extracts: Serenoa serrulata, Epilobium roseum, Curcubita pepo, Epilobium angustifolium, Tropaeolum majus, Terminalia chebula, Porphyridium cruentum.
Les proportions préférées sont, en pourcentage en poids de la composition: - pour l'extrait de Serenoa: de 0,01 à 10%, de préférence de 0,01 à 5%, pour l'extrait d'Epilobium: de 0,01 à 10%, de préférence de 0,01 à 5%, pour l'extrait de Cucurbita: de 0,01 à 10%, de préférence de 0,01 à 5%, pour l'extrait d'Epilobium: de 0,01 à 0,5%, - pour l'extrait de Tropaeolum: de 0,01 à 10%, de préférence de 0,01 à 5%, - pour l'extrait de Terminalia: de 0,01 à 10%, de préférence de 0,01 à 5%, - pour l'extrait de Porphyridium: io - de 0,01 à 10%, de préférence de 0, 01 à 5%. The preferred proportions are, as a percentage by weight of the composition: for the Serenoa extract: from 0.01 to 10%, preferably from 0.01 to 5%, for the Epilobium extract: from 0, 0.1 to 10%, preferably from 0.01 to 5%, for the Cucurbita extract: from 0.01 to 10%, preferably from 0.01 to 5%, for the Epilobium extract: from 0 0.1 to 0.5%, - for the Tropaeolum extract: from 0.01 to 10%, preferably from 0.01 to 5%, - for the Terminalia extract: from 0.01 to 10%, preferably from 0.01 to 5%, for the Porphyridium extract: from 0.01 to 10%, preferably from 0.01 to 5%.
Ces extraits sont obtenus par des techniques standards d'extraction connues de l'homme du métier. These extracts are obtained by standard extraction techniques known to those skilled in the art.
L'extrait de Serenoa serrulata (sabal) peut être obtenu à partir du fruit 15 séché ou partiellement séché, entier ou broyé sous forme de poudre. Le sabal est un extrait lipido-stérolique préparé par extraction des composants des fruits qui sont solubles dans les graisses. Serenoa serrulata (sabal) extract can be obtained from dried or partially dried fruit, whole or ground into powder form. Sabal is a lipid-sterol extract prepared by extracting fruit components that are soluble in fat.
Les extraits végétaux peuvent être incorporés dans diverses compositions pour soins capillaires, et notamment des shampooings, des lotions de mise en plis, des lotions traitantes, des crèmes ou des gels coiffants, des compositions de teintures (notamment teintures d'oxydation) éventuellement sous forme de shampooings colorants, des lotions restructurantes pour les cheveux, des compositions de permanente (notamment des compositions pour le premier temps d'une permanente), des lotions ou des gels antichute, des shampooings anti- parasitaires, etc... The plant extracts may be incorporated into various hair care compositions, and in particular shampoos, styling lotions, treatment lotions, creams or styling gels, dye compositions (especially oxidation dyes), optionally in the form of coloring shampoos, restructuring lotions for the hair, permanent compositions (especially compositions for the first time of a perm), lotions or anti-fall gels, anti-parasitic shampoos, etc.
Les compositions peuvent ainsi être sous forme de solutions aqueuses, alcooliques ou hydroalcooliques, ou sous forme de crèmes, de gels, d'émulsions, de mousses ou encore sous forme de compositions pour aérosol comprenant également un agent propulseur sous pression. The compositions may thus be in the form of aqueous, alcoholic or aqueous-alcoholic solutions, or in the form of creams, gels, emulsions, foams or in the form of aerosol compositions also comprising a propellant under pressure.
Selon un mode préféré de réalisation de l'invention, la composition est une lotion capillaire, de préférence de formule suivante: Ingrédients % (poids) Eau 68,245 Alcool éthylique dénaturé 20 Extrait de fruit Serenoa serrulata 10 Extrait d'Epibobium roseum Extrait de graine de Cucurbita pepo (potiron) Lécithine 0,2 Glycérine 0,16 Extrait d'Epilobium angustifolium 0,09 Extrait de Tropaelum majus 0,056 Extrait de Terminalia chebula 0,03 Extrait de Porphyridium cruentum 0,024 Hydroxyéthylcellulose 0,02 Chlorure d'hydroxypropyltrimonium, 0,02 hydroxypropyl guar Acétate de tocophéryle 0,01 Phénoxyéthanol 0,02 Chlorure de myristalkonium & 0,035 quaternium-14 PEG-40 huile de ricin hydrogénée 0,25 Urée imidazolidinique 0,05 Chitosan (acide carboxylique 0, 09 pyrrolidone) Parfum 0,7 La composition au sabal selon l'invention a fait l'objet d'études chez 5 l'homme et la femme, qui ont démontré son utilité pour diminuer la séborrhée et stimuler la pousse des cheveux et empêcher la chute des cheveux. According to a preferred embodiment of the invention, the composition is a hair lotion, preferably of the following formula: Ingredients% (weight) Water 68,245 Denatured ethyl alcohol 20 Fruit extract Serenoa serrulata 10 Epibobium roseum extract Seed extract Cucurbita pepo (pumpkin) Lecithin 0.2 Glycerin 0.16 Extract of Epilobium angustifolium 0.09 Extract of Tropaelum majus 0.056 Extract of Terminalia chebula 0.03 Extract of Porphyridium cruentum 0.024 Hydroxyethylcellulose 0.02 Hydroxypropyltrimonium chloride, 0.02 hydroxypropyl guar Tocopheryl acetate 0.01 Phenoxyethanol 0.02 Myristalkonium chloride & 0.035 quaternium-14 PEG-40 Hydrogenated castor oil 0.25 Imidazolidine urea 0.05 Chitosan (carboxylic acid 0.09 pyrrolidone) Fragrance 0.7 The composition Sabal according to the invention has been studied in man and woman, who have demonstrated its usefulness in decreasing seborrhea and stimulating hair growth, and to fish for hair loss.
Test de tolérance L'objet de cette étude consiste à apprécier la tolérance locale de la 5 composition cosmétique après applications répétées dans les conditions normales d'emploi. Tolerance Test The object of this study is to assess the local tolerance of the cosmetic composition after repeated applications under normal conditions of use.
L'étude a été menée sur des sujets affiliés à la Sécurité Sociale, âgés de plus de 18 ans, ne présentant aucune lésion au niveau des zones cibles, du cuir chevelu. The study was conducted on topics affiliated with the Social Security, aged over 18, with no lesions in the target areas, the scalp.
io Les sujets ont suivi le protocole suivant: - J1 (inclusion) : après examen des zones cibles, le produit est appliqué dans les conditions normales d'emploi par la technicienne du laboratoire; - JI à Jn: le produit est appliqué par le sujet dans les conditions normales d'emploi; Jn (fin d'étude) : un examen des zones cibles est réalisé, 8 à 12 heures après la dernière application. The subjects followed the following protocol: J1 (inclusion): after examination of the target zones, the product is applied under normal conditions of use by the laboratory technician; - JI to Jn: the product is applied by the subject under normal conditions of use; Jn (end of study): a review of the target areas is performed, 8 to 12 hours after the last application.
Un examen et une évaluation macrocospique des réactions sont menés: - A J1: les zones cibles sont examinées 30 minutes après application du produit et en fin d'étude, un examen des zones cibles est réalisé afin de déceler 20 toute manifestation objective d'intolérance (érythème, oedème.. .). A macrocospheric examination and evaluation of the reactions are carried out: - At D1: the target areas are examined 30 minutes after application of the product and at the end of the study, a review of the target areas is carried out in order to detect any objective manifestation of intolerance (erythema, edema, etc.).
Les sujets sont également interrogés sur les signes fonctionnels éventuellement ressentis. Leurs commentaires éventuels sont soigneusement notés en respectant les termes employés par le sujet (par exemple: sensation de brûlure, picotements, démangeaisons...). The subjects are also asked about the functional signs that may be felt. Their comments are carefully noted in the terms used by the subject (eg: burning sensation, tingling, itching ...).
Déroulement de l'étude La composition selon l'invention a été appliquée dans les conditions normales d'emploi, trois fois par semaine, sur une période de trois semaines, soit neuf applications. Course of the study The composition according to the invention was applied under the normal conditions of use, three times a week, over a period of three weeks, ie nine applications.
21 sujets, 3 femmes et 18 hommes, âgés de 23 à 60 ans (moyenne 42,2 ans), ont été présélectionnés pour l'essai. Tous présentaient une perte excessive des cheveux et un cuir chevelu à tendance grasse. Un d'entre eux, présentant un pityriasis stéatoïde du cuir chevelu, a été exclu de l'essai. 21 subjects, 3 women and 18 men, aged 23 to 60 (mean 42.2 years), were short-listed for the trial. All had excessive hair loss and a scalp with a greasy tendency. One of them, with a steatoid pityriasis of the scalp, was excluded from the trial.
En fin d'essai, il a été demandé à tous les volontaires d'évaluer les qualités cosmétiques du produit à l'étude et de se prononcer sur leur éventuel souhait de poursuivre l'utilisation du produit et de l'acheter. At the end of the test, all volunteers were asked to evaluate the cosmetic qualities of the product under study and to decide on their wish to continue using the product and to buy it.
La tolérance du produit a été vérifiée et par le sujet et par le médecin, 5 aucun effet indésirable n'ayant été noté. The tolerance of the product was checked by both the subject and the physician, with no adverse effects noted.
Les qualités cosmétiques de la composition selon l'invention ont reçu une appréciation favorable, la composition permettant notamment de diminuer la séborrhée, et la perte des cheveux. The cosmetic qualities of the composition according to the invention have been favorably assessed, the composition notably making it possible to reduce seborrhea and the loss of hair.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0403167A FR2867973A1 (en) | 2004-03-26 | 2004-03-26 | Capillary care composition, useful to e.g. treat alopecia, comprises Sabal, which is an extract of Serenoa serrulata in association with a vehicle |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0403167A FR2867973A1 (en) | 2004-03-26 | 2004-03-26 | Capillary care composition, useful to e.g. treat alopecia, comprises Sabal, which is an extract of Serenoa serrulata in association with a vehicle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR2867973A1 true FR2867973A1 (en) | 2005-09-30 |
Family
ID=34945832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR0403167A Pending FR2867973A1 (en) | 2004-03-26 | 2004-03-26 | Capillary care composition, useful to e.g. treat alopecia, comprises Sabal, which is an extract of Serenoa serrulata in association with a vehicle |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2867973A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2954124A1 (en) * | 2009-12-18 | 2011-06-24 | Fabre Pierre Dermo Cosmetique | USE OF 2,3-DIHYDROXYPROPYL DODECANOATE FOR THE TREATMENT OF SEBORRHEA |
| US20170135949A1 (en) * | 2015-11-18 | 2017-05-18 | Seiberg Consulting, LLC | Compositions containing natural extracts and use thereof for skin and hair |
| US10004678B2 (en) * | 2013-08-22 | 2018-06-26 | Lucas Meyer Cosmetics Canada Inc. | Anti-dandruff compositions, and methods of use thereof |
| US11020340B2 (en) | 2017-09-18 | 2021-06-01 | Seiberg Consulting, LLC | Compositions containing natural products and use thereof for skin and hair |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997002041A1 (en) * | 1995-07-03 | 1997-01-23 | Crandall Wilson T | Transdermal and oral treatment of androgenic alopecia |
| US6019976A (en) * | 1997-03-26 | 2000-02-01 | Bryant; Andrew Edward | Formulations for treating male pattern baldness containing Serenoa repens, Vitamin B6, Vitamin B3, zinc and L-Arginine |
| WO2000056269A2 (en) * | 1999-03-19 | 2000-09-28 | Steven Chizick | Natural preparation for treatment of male pattern hair loss |
| FR2791255A1 (en) * | 1999-03-26 | 2000-09-29 | Greentech Sa | Anti-androgenic compositions contain a vegetable-based complex derived from sabal, marrow and epilobium, for prevention of hair regrowth, loss of hair, and seborrhea |
| US20020028257A1 (en) * | 2000-02-18 | 2002-03-07 | Chris Catalfo | Compositions and methods for treating baldness |
| WO2002019974A1 (en) * | 2000-09-04 | 2002-03-14 | Ravi Shrivastava | Synergetic combinations based on plants for treating hair loss |
| US6358541B1 (en) * | 2000-05-03 | 2002-03-19 | David S. Goodman | Topical preparation for the treatment of hair loss |
| WO2004010958A2 (en) * | 2002-07-31 | 2004-02-05 | Shaklee Corporation | A method for maximizing scalp health and inducing enhanced visual and tactile hair quality |
-
2004
- 2004-03-26 FR FR0403167A patent/FR2867973A1/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997002041A1 (en) * | 1995-07-03 | 1997-01-23 | Crandall Wilson T | Transdermal and oral treatment of androgenic alopecia |
| US6019976A (en) * | 1997-03-26 | 2000-02-01 | Bryant; Andrew Edward | Formulations for treating male pattern baldness containing Serenoa repens, Vitamin B6, Vitamin B3, zinc and L-Arginine |
| WO2000056269A2 (en) * | 1999-03-19 | 2000-09-28 | Steven Chizick | Natural preparation for treatment of male pattern hair loss |
| FR2791255A1 (en) * | 1999-03-26 | 2000-09-29 | Greentech Sa | Anti-androgenic compositions contain a vegetable-based complex derived from sabal, marrow and epilobium, for prevention of hair regrowth, loss of hair, and seborrhea |
| US20020028257A1 (en) * | 2000-02-18 | 2002-03-07 | Chris Catalfo | Compositions and methods for treating baldness |
| US6358541B1 (en) * | 2000-05-03 | 2002-03-19 | David S. Goodman | Topical preparation for the treatment of hair loss |
| WO2002019974A1 (en) * | 2000-09-04 | 2002-03-14 | Ravi Shrivastava | Synergetic combinations based on plants for treating hair loss |
| WO2004010958A2 (en) * | 2002-07-31 | 2004-02-05 | Shaklee Corporation | A method for maximizing scalp health and inducing enhanced visual and tactile hair quality |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2954124A1 (en) * | 2009-12-18 | 2011-06-24 | Fabre Pierre Dermo Cosmetique | USE OF 2,3-DIHYDROXYPROPYL DODECANOATE FOR THE TREATMENT OF SEBORRHEA |
| WO2011073370A3 (en) * | 2009-12-18 | 2012-07-19 | Pierre Fabre Dermo-Cosmetique | Use of 2,3-dihydroxypropyl dodecanoate for treating seborrhea |
| CN102781415A (en) * | 2009-12-18 | 2012-11-14 | 皮埃尔·法布尔皮肤化妆品公司 | Use of 2,3-dihydroxypropyl dodecanoate for treating seborrhea |
| US9101785B2 (en) | 2009-12-18 | 2015-08-11 | Pierre Fabre Dermo-Cosmetique | Use of 2,3-dihydroxypropyl dodecanoate for treating seborrhoea |
| US10004678B2 (en) * | 2013-08-22 | 2018-06-26 | Lucas Meyer Cosmetics Canada Inc. | Anti-dandruff compositions, and methods of use thereof |
| US20170135949A1 (en) * | 2015-11-18 | 2017-05-18 | Seiberg Consulting, LLC | Compositions containing natural extracts and use thereof for skin and hair |
| US10206861B2 (en) * | 2015-11-18 | 2019-02-19 | Seiberg Consulting, LLC | Compositions containing natural extracts and use thereof for skin and hair |
| US10675233B2 (en) | 2015-11-18 | 2020-06-09 | Seiberg Consulting, LLC | Compositions containing natural extracts and use thereof for skin and hair |
| US11020340B2 (en) | 2017-09-18 | 2021-06-01 | Seiberg Consulting, LLC | Compositions containing natural products and use thereof for skin and hair |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0660698B1 (en) | Cosmetic or dermatologic composition containing at least one saponine of the ginsenoside type, and its applications particularly to hair care | |
| EP3651730B1 (en) | New composition for straightening hair | |
| EP1688128B1 (en) | Method for treating keratinic fibres and the scalp with a composition containing a derivative of glucose and vitamin F | |
| EP2512420B1 (en) | Use of 2,3-dihydroxypropyl dodecanoate for treating seborrhea | |
| FR2811567A1 (en) | COMPOSITION, ESPECIALLY COSMETIC, COMPRISING DHEA AND / OR A PRECURSOR OR DERIVATIVE THEREOF, IN ASSOCIATION WITH AT LEAST ONE NO-SYNTHASE INHIBITOR | |
| EP0831865B1 (en) | Hair composition comprising a myrtle extract, preparation process and utilization particularly for an anti-dandruff treatment | |
| FR2848846A1 (en) | COSMETIC USE OF ASCORBIC ACID DERIVATIVES AS BLANCHING AGENTS | |
| FR2867973A1 (en) | Capillary care composition, useful to e.g. treat alopecia, comprises Sabal, which is an extract of Serenoa serrulata in association with a vehicle | |
| CA3119556A1 (en) | Garcinia mangostana extract for promoting hair growth | |
| FR3091162A1 (en) | Cosmetic and / or nutraceutical use of a bark extract of Eperua falcata | |
| EP1303253A1 (en) | Composition, in particular cosmetic, comprising dhea and/or a precursor or derivative thereof, combined with at least a glycation inhibiting agent | |
| WO2020020791A1 (en) | Lespedeza capitata extract for use in the field of hair care | |
| WO2012131274A1 (en) | Use, as antidandruff agent, of (ethoxyhydroxyphenyl)alkyl ketone or ethoxyhydroxyalkylphenol compounds | |
| FR2826261A1 (en) | COMPOSITION FOR TOPICAL USE COMPRISING A CYTOTOXIC PRODUCT AND ITS USE IN THE TREATMENT OF ALOPECHE | |
| FR3063901A1 (en) | ASSOCIATION OF AQUEOUS EXTRACTS OF CRESSOR AND CAPUCIN AND ATP IN THE TREATMENT OF ALOPECIA | |
| EP1348421A2 (en) | A method of thickening and styling human keratinous fibres using a particular catalytic system | |
| FR2951943A1 (en) | Cosmetic use of Rubus fructicosus and/or its extract as agent to reduce or prevent whitening of hair and/or body hair | |
| FR2895238A1 (en) | USE OF A SORBITAN OXYALKYLENE ESTER FOR SOOTHING SCALP, AND METHOD FOR COSMETIC TREATMENT OF SCALP | |
| JP2001163762A (en) | Sliming agent | |
| EP1475376A1 (en) | Hair composition containing a pyrimidine-n-oxide derivative and its use to stimulate keratinic fiberes growth and/or preventing their loss | |
| EP3261633A1 (en) | Cosmetic or dermatological composition for treating alopecia | |
| JP3628196B2 (en) | Antioxidant and composition containing the same | |
| FR3068890A1 (en) | NEW COMPOSITION FOR THE SMOOTHING OF HAIR | |
| EP1829523A1 (en) | Cosmetic use of an N-oxide derivative of theophylline | |
| FR2951940A1 (en) | Cosmetic use of plant of genus Caesalpinia and/or its extract and/or a composition containing the plant to reduce, delay, prevent whitening of hair and/or body hair |